Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Raymond James & Associates

Raymond James & Associates decreased its holdings in Exponent, Inc. (NASDAQ:EXPO) by 3.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 467,027 shares of the business services provider’s stock after selling 17,461 shares during the quarter. Raymond James & Associates owned 0.92% of Exponent worth $41,117,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Kayne Anderson Rudnick Investment Management LLC raised its holdings in shares of Exponent by 9.5% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,685,472 shares of the business services provider’s stock valued at $401,076,000 after acquiring an additional 408,295 shares during the last quarter. Conestoga Capital Advisors LLC raised its holdings in shares of Exponent by 1.2% during the third quarter. Conestoga Capital Advisors LLC now owns 2,444,269 shares of the business services provider’s stock valued at $209,229,000 after acquiring an additional 30,012 shares during the last quarter. State Street Corp raised its holdings in shares of Exponent by 0.4% during the third quarter. State Street Corp now owns 1,704,373 shares of the business services provider’s stock valued at $149,422,000 after acquiring an additional 6,352 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Exponent by 5.1% during the second quarter. Geode Capital Management LLC now owns 1,178,846 shares of the business services provider’s stock valued at $110,010,000 after acquiring an additional 57,592 shares during the last quarter. Finally, Morgan Stanley raised its holdings in shares of Exponent by 87.7% during the fourth quarter. Morgan Stanley now owns 1,057,052 shares of the business services provider’s stock valued at $104,743,000 after acquiring an additional 493,847 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent Price Performance

EXPO stock opened at $82.69 on Friday. The business has a 50 day simple moving average of $81.16 and a 200-day simple moving average of $83.05. The firm has a market capitalization of $4.18 billion, a PE ratio of 42.41 and a beta of 0.68. Exponent, Inc. has a 1 year low of $64.61 and a 1 year high of $101.65.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, February 1st. The business services provider reported $0.41 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.03). The company had revenue of $113.87 million during the quarter, compared to analysts’ expectations of $119.11 million. Exponent had a net margin of 18.69% and a return on equity of 28.49%. Exponent’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same quarter last year, the company earned $0.44 earnings per share. On average, equities research analysts expect that Exponent, Inc. will post 1.76 EPS for the current year.

Exponent Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, March 8th were given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.35%. This is a positive change from Exponent’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend was Thursday, March 7th. Exponent’s dividend payout ratio is presently 57.44%.

Insider Buying and Selling

In related news, insider Eric Guyer sold 3,367 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $78.49, for a total value of $264,275.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

EXPO has been the subject of a number of research analyst reports. Truist Financial reduced their target price on Exponent from $110.00 to $95.00 and set a “buy” rating for the company in a report on Friday, February 2nd. StockNews.com upgraded Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.